{"url_path":"/sec/bcda/8-k/2026-05-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 **         **Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/925741/0001437749-26-017222-index.html","accession_number":"0001437749-26-017222","cik":"0000925741","ticker":"BCDA","issuer_name":"BioCardia, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/925741/0001437749-26-017222-index.html","primary_entity_key":"0000925741","primary_entity_name":"BioCardia, Inc."},"word_count":126,"has_tables":true,"body_markdown":"**Item 2.02.**         **Results of Operations and Financial Condition.**\n\n \n\nOn May 15, 2026, BioCardia, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.\n\n \n\nThe information in this Item 2.02, including the Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing."}